Does RITUXIMAB Cause Hepatitis b reactivation? 914 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 914 reports of Hepatitis b reactivation have been filed in association with RITUXIMAB (Rituxan). This represents 0.5% of all adverse event reports for RITUXIMAB.
914
Reports of Hepatitis b reactivation with RITUXIMAB
0.5%
of all RITUXIMAB reports
374
Deaths
220
Hospitalizations
How Dangerous Is Hepatitis b reactivation From RITUXIMAB?
Of the 914 reports, 374 (40.9%) resulted in death, 220 (24.1%) required hospitalization, and 41 (4.5%) were considered life-threatening.
Is Hepatitis b reactivation Listed in the Official Label?
Yes, Hepatitis b reactivation is listed as a known adverse reaction in the official FDA drug label for RITUXIMAB.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Hepatitis b reactivation?
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
LAMIVUDINE (308)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
TENOFOVIR DISOPROXIL (162)
Which RITUXIMAB Alternatives Have Lower Hepatitis b reactivation Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE